Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Notes Payables (2020 - 2021)

Capricor Therapeutics (CAPR) has 3 years of Notes Payables data on record, last reported at $282691.0 in Q1 2021.

  • For Q1 2021, Notes Payables changed N/A year-over-year to $282691.0; the TTM value through Mar 2021 reached $282691.0, changed N/A, while the annual FY2020 figure was $246689.0, N/A changed from the prior year.
  • Notes Payables reached $282691.0 in Q1 2021 per CAPR's latest filing, up from $246689.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $282691.0 in Q1 2021 and bottomed at $139927.0 in Q2 2020.